Novel vaccine safety issues and areas that would benefit from further research

• Annelies Wilder-Smith,
• Peter G Smith,
• Jacqueline E Tate,
• Umesh D Parashar,
• Daniel A Salmon,
• Paul Henri Lambert,
• Hanna M Nohynek,
• Julianne Gee,
• Kenneth Y Hartigan-Go,
• Patrick Louis F Zuber

Affiliations

Annelies Wilder-Smith

London School of Hygiene & Tropical Medicine, London, London, UK

Peter G Smith

MRC International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK

Jacqueline E Tate

Divison of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Umesh D Parashar

Divison of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Daniel A Salmon

Global Disease Epidemiology and Control, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA

Paul Henri Lambert

Centre of Vaccinology, University of Geneva, Geneva, GE, Switzerland

Hanna M Nohynek

Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Uusimaa, Finland

Julianne Gee

Division of Healthcare Quality Promotion, National Center of Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, USA

Kenneth Y Hartigan-Go

Asian Institute of Management, Makati City, Philippines

Patrick Louis F Zuber

Essential Medicines and Health Products, Organisation Mondiale de la Sante, Geneve, Switzerland